Narjes Saheb Sharif-Askari, Fatemeh Saheb Sharif-Askari, Ola Salam Bayram, Shirin Hafezi, Hawra Ali Hussain Alsayed, Fathima Kasim, Bushra Mdkhana, Balachandar Selvakumar, Habiba S Alsafar, Rabih Halwani
BACKGROUND: Autoantibodies have been demonstrated to dampen the interferon (IFN) response in viral infections. Elevated levels of these preexisting autoantibodies (aAbs) decrease basal interferon levels, increasing susceptibility to severe infections. OBJECTIVES: This study aimed to evaluate the prevalence of type I IFN aAbs in both plasma and saliva from COVID-19 patients, analyze their neutralizing activity, and examine their associations with clinical outcomes, including the need for mechanical ventilation and in-hospital mortality...
March 27, 2024: Heart & Lung: the Journal of Critical Care